Meridian Bioscience (VIVO) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $5.45 -1.27%
Financial Fact:
DILUTED EARNINGS PER COMMON SHARE: 0.13
Today's EPS Names:
DTGI, CRMT, MAYS, More
Financial Fact:
DILUTED EARNINGS PER COMMON SHARE: 0.13
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Meridian Bioscience (NASDAQ: VIVO) reported Q4 EPS of $0.20, $0.01 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $47.1 million versus the consensus estimate of $46.6 million.
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Vail Resorts taps bankers for potential activist defense, Semafor reports
- HCB shareholders approve Independent Bank's acquisition deal
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
